UROPLASTY INC-NEW
UPI
UPI was delisted on the 31st of March, 2015.
0 hedge funds and large institutions have $0 invested in UROPLASTY INC-NEW in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 31 closing their positions.
100% less funds holding
Funds holding: 31 → 0 (-31)
100% less capital invested
Capital invested by funds: $10.8M → $0 (-$10.8M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 31
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Amici Capital
New York
|
-$2.61M |
| 2 |
O
OrbiMed
New York
|
-$1.66M |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.66M |
| 4 |
PA
Perceptive Advisors
New York
|
-$1.18M |
| 5 |
RCP
Rothschild Capital Partners
New York
|
-$731K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Simplex Trading
Chicago,
Illinois
| – | -$2K | -2,000 | Closed |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$2 | -1,230 | Closed |
|
28
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -1,000 | Closed |
|
UPI Hedge Fund Activity: Q2 2015 in Review
0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in UROPLASTY INC-NEW (UPI) for Q2 2015, worth a combined $0 — down 100% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of UPI and 0 opened new positions — a net loss of 31 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Amici Capital, exiting entirely with an estimated $2.61M sold.
- 0 institutional investors held UROPLASTY INC-NEW (UPI) as of Q2 2015, down from 31 in Q1 2015.
- Funds reported $0 of UROPLASTY INC-NEW stock for Q2 2015, down 100% quarter-over-quarter.
- 0 funds opened new UROPLASTY INC-NEW positions in Q2 2015 and 31 closed out, a net change of -31 holders.
- The largest UROPLASTY INC-NEW seller in Q2 2015 was Amici Capital, an estimated $2.61M sold.
Based on aggregated 13F filings for Q2 2015.